S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
The Financial Day of Reckoning Has Begun (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Myanmar executions revive pressure for more sanctions
3 Stocks Set to Lead the Nasdaq Bull Market
Stocks higher on Wall Street; economic worries hit oil price
126% Average Gains While Stocks Crash (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
The Financial Day of Reckoning Has Begun (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Myanmar executions revive pressure for more sanctions
3 Stocks Set to Lead the Nasdaq Bull Market
Stocks higher on Wall Street; economic worries hit oil price
126% Average Gains While Stocks Crash (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
The Financial Day of Reckoning Has Begun (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Myanmar executions revive pressure for more sanctions
3 Stocks Set to Lead the Nasdaq Bull Market
Stocks higher on Wall Street; economic worries hit oil price
126% Average Gains While Stocks Crash (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
The Financial Day of Reckoning Has Begun (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Myanmar executions revive pressure for more sanctions
3 Stocks Set to Lead the Nasdaq Bull Market
Stocks higher on Wall Street; economic worries hit oil price
126% Average Gains While Stocks Crash (Ad)pixel
NYSE:NSPR

InspireMD - NSPR Stock Forecast, Price & News

$1.92
-0.01 (-0.52%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.90
$1.96
50-Day Range
$1.75
$2.11
52-Week Range
$1.68
$5.06
Volume
23,849 shs
Average Volume
24,594 shs
Market Capitalization
$16.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NSPR stock logo

About InspireMD (NYSE:NSPR) Stock

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

InspireMD Trading Up 0.5 %

Shares of NYSE:NSPR traded up $0.01 during midday trading on Monday, hitting $1.94. 1,050 shares of the stock were exchanged, compared to its average volume of 24,599. InspireMD has a twelve month low of $1.68 and a twelve month high of $5.06. The company has a 50 day moving average price of $1.95 and a 200-day moving average price of $2.38.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on InspireMD in a report on Tuesday, August 9th. They issued a "sell" rating for the company.

Receive NSPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter.

NSPR Stock News Headlines

See More Headlines
Receive NSPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter.

NSPR Company Calendar

Today
8/15/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Net Income
$-14,920,000.00
Net Margins
-334.66%
Pretax Margin
-333.79%

Debt

Sales & Book Value

Annual Sales
$4.49 million
Book Value
$4.15 per share

Miscellaneous

Free Float
8,007,000
Market Cap
$16.00 million
Optionable
Optionable
Beta
1.27

Key Executives

  • Mr. Marvin L. Slosman (Age 57)
    Pres, CEO & Director
    Comp: $603.49k
  • Mr. Craig Shore (Age 61)
    CFO, Chief Admin. Officer, Sec. & Treasurer
    Comp: $625.69k
  • Mr. Roei Samuri
    VP of Operations
  • Mr. Andrea Tommasoli
    Sr. VP of Global Sales & Marketing
  • Mr. Amir Kohen
    VP of Fin. & International HR
  • Dr. Sol J. Barer Ph.D. (Age 75)
    Special Advisor to the Board













NSPR Stock - Frequently Asked Questions

How have NSPR shares performed in 2022?

InspireMD's stock was trading at $2.67 at the start of the year. Since then, NSPR shares have decreased by 27.3% and is now trading at $1.94.
View the best growth stocks for 2022 here
.

When is InspireMD's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our NSPR earnings forecast
.

What other stocks do shareholders of InspireMD own?
What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE) under the ticker symbol "NSPR."

How do I buy shares of InspireMD?

Shares of NSPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $1.94.

How much money does InspireMD make?

InspireMD (NYSE:NSPR) has a market capitalization of $16.15 million and generates $4.49 million in revenue each year. The company earns $-14,920,000.00 in net income (profit) each year or ($2.22) on an earnings per share basis.

How can I contact InspireMD?

InspireMD's mailing address is 4 MENORAT HAMAOR ST., TEL AVIV L3, 6744832. The official website for the company is www.inspire-md.com. The company can be reached via phone at 9728887766804 or via email at craigs@inspiremd.com.

This page (NYSE:NSPR) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.